Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 225 of 1631 entries
View as:

Qlaira Post-authorization Safety Study Related to Most Common Adverse Events in Mexican Women Who Wish to Avoid Pregnancy

Phase: N/A Priority: Normal
NCT ID: NCT01602770 Org: User:
Start: 02/06/15 End: 10/31/17 Due: 10/31/18

A Study to Learn More About How Well Elinzanetant Works and How Safe it is for the Treatment of Vasomotor Symptoms (Hot Flashes) That Are Caused by Hormonal Changes Over 26 Weeks in Women Who Have Been Through the Menopause (OASIS-2)

Phase: N/A Priority: Normal
NCT ID: NCT05099159 Org: User:
Start: 10/29/21 End: 10/10/23 Due: 10/10/24

Human Photoallergy Test

Phase: N/A Priority: Normal
NCT ID: NCT02750449 Org: User:
Start: 05/09/16 End: 07/01/16 Due: 07/01/17

A Trial to Learn How BAY1834845 and BAY1830839 Affect Inflammation When Taken by Mouth Twice a Day for 7 Days in a Row in Healthy Male Participants

Phase: N/A Priority: Normal
NCT ID: NCT05003089 Org: User:
Start: 06/28/21 End: 01/20/22 Due: 01/20/23

Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding

Phase: N/A Priority: Normal
NCT ID: NCT01638923 Org: User:
Start: 06/30/12 End: 06/30/15 Due: 06/30/16

Benefit-Risk Of Arterial THrombotic prEvention With Rivaroxaban for Atrial Fibrillation in France

Phase: N/A Priority: Normal
NCT ID: NCT02864758 Org: User:
Start: 09/08/16 End: 09/30/18 Due: 09/30/19

Observational Study to Analyse the Impact of Nurse Support and Disease Related Factors on Long- Term Adherence to Betaferon Treatment

Phase: N/A Priority: Normal
NCT ID: NCT00787657 Org: User:
Start: 06/30/08 End: 10/31/14 Due: 10/31/15

A 3rd/4th Line Placebo-controlled Trial of Sorafenib in Patients With Predominantly Non Squamous Non-Small Cell Lung Cancer (NSCLC).

Phase: N/A Priority: Normal
NCT ID: NCT00863746 Org: User:
Start: 04/30/09 End: 04/30/13 Due: 04/30/14

Maintenance Treatment of Anemia in Pre-dialysis Subjects With Chronic Kidney Disease on Darbepoetin Treatment Versus BAY85-3934

Phase: N/A Priority: Normal
NCT ID: NCT02021409 Org: User:
Start: 01/28/14 End: 11/23/15 Due: 11/23/16

BAY43-9006 (Sorafenib) Versus Interferon Alpha-2a in Patients With Unresectable and/or Metastatic Renal Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00117637 Org: User:
Start: 06/30/05 End: 03/31/09 Due: 03/31/10

An Observational Study to Learn More About Treatment Patterns and Factors Determining the Choice of Treatment in Canadian Men With Metastatic Hormone Sensitive Prostate Cancer in Routine Medical Care

Phase: N/A Priority: Normal
NCT ID: NCT06874114 Org: User:
Start: 02/28/25 End: 12/31/26 Due: 12/31/27

Evaluation of Physician Knowledge of Safety and Safe Use Information for Aflibercept in Canada

Phase: N/A Priority: Normal
NCT ID: NCT02585401 Org: User:
Start: 02/18/16 End: 05/19/16 Due: 05/19/17

Study in Healthy Adult Male Participants to Gather Information How the Human Body Absorbs, Distributes and Excretes the Study Drug Selitrectinib Including the Effect of the Interaction of Food With the Study Drug on the Human Body

Phase: N/A Priority: Normal
NCT ID: NCT04275960 Org: User:
Start: 02/28/20 End: 11/30/20 Due: 11/30/21

HPA Axis Study in Japanese Adults

Phase: N/A Priority: Normal
NCT ID: NCT01407510 Org: User:
Start: 05/09/11 End: 04/15/12 Due: 04/15/13

Dose-confirmatory Bridging Study in Total Knee Replacement

Phase: N/A Priority: Normal
NCT ID: NCT01206972 Org: User:
Start: 10/31/10 End: 06/30/11 Due: 06/30/12

Magnevist® Injection Enhanced MRA at Two Dose Levels Compared to Non Contrast MRA for the Detection of Structural Abnormalities of the Infrarenal Aorta and Peripheral Arteries

Phase: N/A Priority: Normal
NCT ID: NCT00185276 Org: User:
Start: 03/31/03 End: 08/31/04 Due: 08/31/05

Magnevist® Injection Enhanced MRA Compared to Non Contrast MRA for the Detection of Structural Abnormalities of the Aortic Arch and Cerebral Branches

Phase: N/A Priority: Normal
NCT ID: NCT00310609 Org: User:
Start: 12/31/03 End: 10/31/04 Due: 10/31/05

A Study to Learn More About How Drug Aflibercept Works in Canadian Patients With Reduced Vision Caused by New Blood Vessels Growing in the Eye (Myopic Choroidal Neovascularization or mCNV)

Phase: N/A Priority: Normal
NCT ID: NCT04524910 Org: User:
Start: 06/16/21 End: 11/11/22 Due: 11/11/23

Scandinavian Mirena Insertion Nulliparous Trial.

Phase: N/A Priority: Normal
NCT ID: NCT00798980 Org: User:
Start: 02/28/07 End: 11/30/09 Due: 11/30/10

An Observational Cross-sectional Study Evaluating the Use of Re-sources and the Sociodemographic and Clinical Characteristics of Patients Diagnosed With Non-valvular Atrial Fibrillation With a Risk of Stroke or Systemic Embolism on Anticoagulant Therapy and Treated in Primary Care Centers

Phase: N/A Priority: Normal
NCT ID: NCT02559232 Org: User:
Start: 09/30/15 End: 03/31/16 Due: 03/31/17

Roniciclib (BAY 1000394) Drug-Drug Interaction (DDI) Study

Phase: N/A Priority: Normal
NCT ID: NCT02457351 Org: User:
Start: 07/31/15 End: 04/30/16 Due: 04/30/17

A Study to Investigate the Time to Onset of Action of 10 mg and 20 mg of Vardenafil Compared to Placebo in Males With Erectile Dysfunction

Phase: N/A Priority: Normal
NCT ID: NCT00665496 Org: User:
Start: 06/30/03 End: 11/30/03 Due: 11/30/04

Drug-drug Interaction Study Between Orally Administered Rifampicin and Vilaprisan

Phase: N/A Priority: Normal
NCT ID: NCT02975440 Org: User:
Start: 11/10/16 End: 04/11/17 Due: 04/11/18

Efficacy and Safety of Rivaroxaban for the Prevention of Stroke in Subjects With Non-Valvular Atrial Fibrillation

Phase: N/A Priority: Normal
NCT ID: NCT00494871 Org: User:
Start: 06/30/07 End: 01/31/10 Due: 01/31/11

Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic VTE(Venous Thromboembolism)

Phase: N/A Priority: Normal
NCT ID: NCT02064439 Org: User:
Start: 03/05/14 End: 11/04/16 Due: 11/04/17